Abstract
Four different genes were identified by immunoscreening of a cDNA expression library from the human prostate cancer cell line DU145 with allogeneic sera from four prostate cancer patients. A cDNA encoding the nucleolar protein No55 was further analysed and shown to be expressed at the mRNA level in several normal tissues, including ovaries, pancreas and prostate and in human prostate cancer cell lines PC-3, PC-3m and LNCaP. By reverse transcriptase/polymerase chain reaction, expression of No55 was several-fold higher in two out of nine prostate cancer primary tumours and two out of two metastatic lesions, compared to normal prostate tissue. Antibodies to No55 were detected in sera from seven out of 47 prostate cancer patients but not in sera from 20 healthy male controls. Sequence analysis of the No55 open reading frame from normal and tumour tissues revealed no tumour-specific mutations. The No55 gene was located to chromosome 17q21, a region reported to be partially deleted in prostate cancer. Considering the immunogenicity of the No55 protein in the tumour host, the expression profile and chromosomal localization of the corresponding gene, studies evaluating No55 as a potential antigen for immunological studies in prostate cancer may be warranted. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Chen Q, Pearlman RE and Moens PB (1992) Isolation and characterization of a cDNA encoding a synaptonemal complex protein. Biochem Cell Biol 70: 1030–1038
Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914–1918
Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A and Old LJ (1998) Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919–6923
Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Cussenot O, Villette JM, Cochand-Priollet B and Berthon P (1998) Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumours. Prostate Suppl 8: 43–51
Fan S, Wang JA, Yuan RQ, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID and Rosen EM (1998) BRCA1 as a potential human prostate tumour suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene 16: 3069–3082
Freeman JW, Hazlewood JE, Bondada V, Cibull ML, Fonagy A, Ochs R, Busch RK and Busch H (1989) Proliferation-related nucleolar antigens P145 and P120 associated with separate nucleolar elements and differences in tissue distribution. Cancer Commun 1: 367–372
Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT and Honn KV (1995) Localization of potential tumour suppressor loci to a <2 Mb region on chromosome 17q in human prostate cancer. Oncogene 11: 1241–1247
Gure AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ and Chen YT (1998) Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumour suppressor gene locus on chromosome 3p21.3. Cancer Res 58: 1034–1041
Harder J, Siebert R, Zhang Y, Matthiesen P, Christophers E, Schlegelberger B and Schroder JM (1997) Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22–p23.1. Genomics 46: 472–475
Hoosein NM (1998) Neuroendocrine and immune mediators in prostate cancer progression. Front. Biosci 3:D1274-9: D1274–D1279
Itoh M, Watanabe M, Yamada Y, Furukawa K, Taniguchi M, Hata T, Schmitt M, Ikeda H, Yamaguchi M, Ohno T, Nakashima K and Shiku H (1999) HUBI is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. Int J Oncol 14: 703–708
Jager E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ and Knuth A (1998) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187: 265–270
Kallakury BV, Sheehan CE, Rhee SJ, Fisher HA, Kaufman RPJ, Rifkin MD and Ross JS (1999) The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2. Cancer 85: 1569–1576
Kawakami Y and Rosenberg SA (1997) Human tumour antigens recognized by T-cells. Immunol Res 16: 313–339
Kloeker S and Wadzinski BE (1999) Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J Biol Chem 274: 5339–5347
Murakami YS, Brothman AR, Leach RJ and White RL (1995) Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 55: 3389–3394
Ochs RL, Stein TWJ, Chan EK, Ruutu M and Tan EM (1996) cDNA cloning and characterization of a novel nucleolar protein. Mol Biol Cell 7: 1015–1024
Ochs RL, Stein TWJ, Peebles CL, Gittes RF and Tan EM (1994) Autoantibodies in interstitial cystitis. J Urol 151: 587–592
Old LJ and Chen YT (1998) New paths in human cancer serology. J Exp Med 187: 1163–1167
Ou SH, Wu F, Harrich D, Garcia-Martinez LF and Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69: 3584–3596
Qiao L, Pizzolo JG and Melamed MR (1994) Effects of suramin on expression of proliferation associated nuclear antigens in DU-145 prostate carcinoma cells. Biochem Biophys Res Commun 201: 581–588
Rosok O, Pedeutour F, Ree AH and Aasheim HC (1999) Identification and characterization of TESK2, a novel member of the LIMK/TESK family of protein kinases, predominantly expressed in testis. Genomics 61: 44–54
Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810–11813
Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M and Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652–658
Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT and Old LJ (1999) Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83: 456–464
Shirao T (1995) The roles of microfilament-associated proteins, drebrins, in brain morphogenesis: a review. J Biochem (Tokyo) 117: 231–236
Spanakis E and Brouty-Boye D (1994) Evaluation of quantitative variation in gene expression. Nucleic Acids Res 22: 799–806
Theoharides TC, Pang X, Letourneau R and Sant GR (1998) Interstitial cystitis: a neuroimmunoendocrine disorder. Ann N Y Acad Sci 840: 619–634
Toda M, Shirao T, Minoshima S, Shimizu N, Toya S and Uyemura K (1993) Molecular cloning of cDNA encoding human drebrin E and chromosomal mapping of its gene. Biochem Biophys Res Commun 196: 468–472
Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G and Pfreundschuh M (1998) Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 95: 5211–5216
Uchida T, Wang C, Sato T, Gao J, Takashima R, Irie A, Ohori M and Koshiba K (1999) BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer. Int J Cancer 84: 19–23
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Fosså, A., Siebert, R., Aasheim, HC. et al. Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. Br J Cancer 83, 743–749 (2000). https://doi.org/10.1054/bjoc.2000.1365
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1365
Keywords
This article is cited by
-
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others
Clinical Reviews in Allergy & Immunology (2022)
-
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer
World Journal of Surgical Oncology (2018)
-
Non-coding RNAs profiling in head and neck cancers
npj Genomic Medicine (2016)
-
Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome
Current Urology Reports (2007)
-
Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome
Current Prostate Reports (2006)